EverImmune engages Biose Industrie to manufacture its leading oncology-related Live Biotherapeutic
Microbiome-focused oncology drug company everImmune, a spin-out from France’s top cancer research center, has signed an agreement with contract development and manufacturing organization (CDMO) Biose Industrie to manufacture the drug substance and finished drug product […]
